Legend Biotech (LEGN) Profit After Tax (2019 - 2025)
Legend Biotech (LEGN) reported Profit After Tax of $30.9 million for Q4 2025, up 17.05% on a YoY basis from $26.4 million in Q4 2024, and up 177.86% quarter-over-quarter from -$39.7 million in Q3 2025.
Legend Biotech (LEGN) Profit After Tax (2019 - 2025) Analysis & Trends
Legend Biotech has reported Profit After Tax for 7 years, with the latest figure at $30.9 million in Q4 2025.
- For the quarter ending Q4 2025, Profit After Tax rose 17.05% year-over-year to $30.9 million; the trailing twelve-month figure through Dec 2025 stood at -$235.1 million (down 32.88% YoY), and the FY2025 full-year result was -$296.8 million, down 267.68% from the prior year.
- Profit After Tax for Q4 2025 stood at $30.9 million, up from -$39.7 million in the prior quarter.
- The five-year high for Profit After Tax was $30.9 million in Q4 2025, with the low at -$199.1 million in Q2 2023.
- Historically, Profit After Tax has averaged -$76.8 million across 5 years, with a median of -$86.6 million in 2021.
- Annual changes were most pronounced in 2022 — Profit After Tax slumped 35570.18% — and 2024, when it soared 18329.78%.
- Legend Biotech's Profit After Tax stood at -$88.3 million in 2021, then sank by 53.82% to -$135.9 million in 2022, then surged by 99.89% to -$144818.0 in 2023, then soared by 18329.78% to $26.4 million in 2024, then increased by 17.05% to $30.9 million in 2025.
- The last three Profit After Tax figures came in at $30.9 million (Q4 2025), -$39.7 million (Q3 2025), and -$125.4 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.63 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.74 Mn |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 727.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30.90 Mn |
| Sep 30, 2025 | -39.69 Mn |
| Jun 30, 2025 | -125.38 Mn |
| Mar 31, 2025 | -100.92 Mn |
| Dec 31, 2024 | 26.40 Mn |
| Sep 30, 2024 | -125.32 Mn |
| Jun 30, 2024 | -18.20 Mn |
| Mar 31, 2024 | -59.79 Mn |
| Dec 31, 2023 | -144,818.00 |
| Sep 30, 2023 | -62.21 Mn |
| Jun 30, 2023 | -199.13 Mn |
| Mar 31, 2023 | -112.10 Mn |
| Dec 31, 2022 | -135.88 Mn |
| Sep 30, 2022 | -84.96 Mn |
| Jun 30, 2022 | -193.23 Mn |
| Mar 31, 2022 | -32.29 Mn |
| Dec 31, 2021 | -88.33 Mn |
| Sep 30, 2021 | -124.75 Mn |
| Jun 30, 2021 | -91.58 Mn |
| Mar 31, 2021 | -90,521.00 |